News | Coronavirus (COVID-19) | March 06, 2020

Chest CTs have low rate of misdiagnosis and can standardize imaging features and transformation rules for rapid diagnosis, yet modality is limited for identification of and distinguishing between specific viruses

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Flowchart shows time difference between positive laboratory test results and positive CT findings for COVID-19 and adenovirus infection in the study group. Image courtesy of American Journal of Roentgenology (AJR)


March 6, 2020 — An article by radiologists from Wuhan, China — published open-access and ahead-of-print in the American Journal of Roentgenology (AJR) — concluded that chest CT had a low rate of misdiagnosis of COVID-19 (3.9 percent, 2/51) and could help standardize imaging features and rules of transformation for rapid diagnosis; however, CT remains limited for the identification of specific viruses and distinguishing between viruses.

Yan Li and Liming Xia at Tongji Hospital in Hubai Province studied the first 51 patients diagnosed with COVID-19 infection confirmed by nucleic acid testing (23 women and 28 men; age range, 26-83 years) and two patients with adenovirus (one woman and one man; ages, 58 and 66 years). In their retrospective cohort of 53 patients, as of February 9, a total of 99 chest CT examinations had been performed.

Comparing image reports of the initial CT study with laboratory test results to identify patterns suggestive of viral infection, according to Li and Xia, "COVID-19 was misdiagnosed as a common infection at the initial CT study in two patients with underlying disease and COVID-19."

Meanwhile, viral pneumonia was correctly diagnosed at the initial CT study in the remaining 49 patients with COVID-19 and two patients with adenovirus.

As Li and Xia explained: "CT of one of the two patients with confirmed adenovirus infection showed ill-defined patchy ground-glass opacities (GGOs), segmental and subpleural consolidations in both lungs, and pleural effusion. CT of the other patient showed subpleural GGOs and consolidation with vascular enlargement, interlobular septal thickening, and air bronchogram sign."

The CT findings seen in Li and Xia's two adenovirus cases were similar to those observed in their COVID-19 cases.

The two authors also found CT features of COVID-19 that differ from both severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV): a reversed halo sign in two patients (3.9 percent) and pulmonary nodules with a halo sign in nine patients (17.6 percent).

"These findings are not mentioned, to our knowledge, in the studies in the literature," the authors noted.

"It is valuable for radiologists to recognize that the CT findings of COVID-19 overlap with the CT findings of diseases caused by viruses from a different family, such as adenovirus, and have differences as well as similarities with viruses within the same family, such as SARS-CoV and MERS-CoV," added Li and Xia.

For more information: www.arrs.org

Additional COVID-19 Resources for Clinicians:

World Health Organization (WHO) COVID-19 situation reports

World Health Organization (WHO) coronavirus information page

U.S. Food and Drug Administration (FDA) COVID-19 information page

Centers for Disease Control (CDC) COVID-19 information page

Related Coronavirus Content:

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Computed Tomography (CT)

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
Subscribe Now